Dive Deep into the World of Psychedelic Integration Join Our Experiential Workshop and Empower Your Community July 8-9, 2023: Saturday and SundayHampton Inn: South County, St. Louis9 – 5 PM Learn how to effectively support others in integrating their psychedelic experiences and make a positive impact on their lives. St. Louis, it’s time to step …
New research published in iScience provides unique insights into how psilocybin alters brain activity during psychedelic experiences. The findings suggest that while the overall activity of the brain becomes more chaotic during the psychedelic state, the brain’s ability to maintain complex interactions in response to external stimulation is not affected. Psilocybin is a naturally occurring …
The Psychedelic Society of St. Louis will be announcing an upcoming psychedelic integration workshop on July 8-9th for anyone who wants to develop and enhance their skills to facilitate their own Psychedelic Integration Circle. You will find more information and be able to reserve your spot on Tuesday when the sign up page goes live. …
James Fadiman is a psychologist and writer who is recognized as one of the pioneering figures in the exploration and study of psychedelics. He was part of the early research on psychedelics in the 1960s, studying their potential therapeutic use and effects on creativity, before the substances became illegal. Fadiman earned his undergraduate degree from …
SALEM, Ore. (AP) — Oregon’s pioneering experiment with legalized magic mushrooms took a step closer to reality as the first “facilitators” who will accompany clients as they experience the drug received their state licenses, authorities said Tuesday. Voters approved the regulated use of psilocybin in a 2020 ballot measure, and anticipation has been building over the past 2 …
Planning a trip? Oregon’s magic mushroom experiment advances Read More »
Mapping Psychedelic Drug Policy Reform As the psychedelic renaissance contributes to a swelling pool of safety and efficacy data pertaining to the potential therapeutic benefits of psychedelic medicine, many localities—particularly in North America—are revising their legal frameworks. This is happening in a number of ways: from the least rigorous incarnation which involves making the enforcement …
The psychedelic renaissance is undergoing a dramatic resurgence. Read More »
Rick Doblin, Ph.D., is the Founder in 1986 and President of the Multidisciplinary Association for Psychedelic Studies (MAPS), a nonprofit that wholly owns its pharmaceutical arm, MAPS Public Benefit Corporation (PBC), which has completed two highly successful Phase 3 studies of MDMA-assisted therapy for PTSD. MAPS PBC stands at a crossroads between obtaining the additional …
SAN JOSE, Calif., April 5, 2023—MAPS Public Benefit Corporation (“MAPS PBC”), a clinical-stage company dedicated to changing the way mental health conditions are treated, announced positive topline results from an observational follow-up study evaluating the long-term safety and efficacy of MDMA-assisted therapy for post–traumatic stress disorder (“PTSD”). Preliminary findings show that participants in this study demonstrated a …
Positive Follow-Up Study on MDMA-Assisted Therapy for Treatment of PTSD Read More »
Matthew W. Johnson, Ph.D. is the Susan Hill Ward Professor in Psychedelics and Consciousness and Professor of Psychiatry and Behavioral Sciences at Johns Hopkins. Psychedelic research is enjoying a renaissance. Recent studies have shown that psychedelic drugs like LSD and psilocybin seem to be a safe and effective method for treating conditions like depression, anxiety, …
The “heroic dose” of psychedelics, according to Johns Hopkins | Dr. Matthew Johnson Read More »
